Thyroid Hormone Induces Terminal Differentiation of Tumor Cells in Medulloblastoma
Thyroid Hormone Induces Terminal Differentiation of Tumor Cells in Medulloblastoma
Dr. Zeng-jie Yang – The Research Institute of Fox Chase Cancer Center, Philadelphia, PA
Modeling relapsed hypodiploid B-cell acute lymphoblastic leukemia using humanized in vivo systems
Modeling relapsed hypodiploid B-cell acute lymphoblastic leukemia using humanized in vivo systems
Dr. Matthew Witkowski – University of Colorado Denver, AMC and DC
Targeting the HMGA1 Chromatin Regulator in MLL1-Rearranged Pediatric Leukemia
Targeting the HMGA1 Chromatin Regulator in MLL1-Rearranged Pediatric Leukemia
Dr. Linda Resar – Johns Hopkins University School of Medicine, Baltimore, MD
Brain Network Organization and Long-Term Cognitive Outcome in Pediatric Brain Tumor Patients
Brain Network Organization and Long-Term Cognitive Outcome in Pediatric Brain Tumor Patients
Dr. Stephanie Perkins – Washington University in St. Louis, St Louis, MO
Discovery of novel MDM2-targeted therapy for pediatric AML
Discovery of novel MDM2-targeted therapy for pediatric AML
Dr. Muxiang Zhou – Emory University, Atlanta, GA
Deciphering the Immune Microenvironment in Alveolar Rhabdomyosarcoma
Deciphering the Immune Microenvironment in Alveolar Rhabdomyosarcoma
Dr. Brian Ladle - Johns Hopkins University School of Medicine, Baltimore, MD
Delineating molecular mechanisms of metastatic dissemination for medulloblastoma therapy
Delineating molecular mechanisms of metastatic dissemination for medulloblastoma therapy
Dr. Baoli Hu – University of Pittsburgh, Pittsburgh, PA
Role of PAX5 mutations in B-cell acute lymphoblastic leukemia
Role of PAX5 mutations in B-cell acute lymphoblastic leukemia
Dr. Zhaohui Gu – Beckman Research Institute of the City of Hope, Duarte, CA
Dual-label optical genome mapping for the identification of novel co-occurring genetic and epigenetic alterations in diffuse midline gliomas
Dual-label optical genome mapping for the identification of novel co-occurring genetic and epigenetic alterations in diffuse midline gliomas
Dr. Miriam Bornhorst – Children's National Health System Department of Neurology, Washington D.C.
Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma
Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma
Dr. Oren Becher – Icahn School of Medicine at Mount Sinai, New York, NY
Activating type I interferon-driven immune surveillance to treat pediatric B-cell acute lymphoblastic leukemia
Activating type I interferon-driven immune surveillance to treat pediatric B-cell acute lymphoblastic leukemia
Beckman Research Institute of the City of Hope, Duarte, CA
Targeting the IKAROS-SAMHD1 axis in KMT2A rearranged B-ALL
Targeting the IKAROS-SAMHD1 axis in KMT2A rearranged B-ALL
Baylor College of Medicine, Houston, TX
Optimizing Pediatric Cancer Immunotherapy with Nano-Targeted Off-the-Shelf Natural Killer T Cells
Optimizing Pediatric Cancer Immunotherapy with Nano-Targeted Off-the-Shelf Natural Killer T Cells
University of Miami, Miami, FL
Characterizing the ENL YEATS epigenetic reading domain as a therapeutic target in pediatric MLL-ENL leukemias
Characterizing the ENL YEATS epigenetic reading domain as a therapeutic target in pediatric MLL-ENL leukemias
The Regents of the University of Michigan, Ann Arbor, MI
Targeting ATR/SPOP Signaling to Overcome Chemotherapy Resistance in Ewing Sarcoma
Targeting ATR/SPOP Signaling to Overcome Chemotherapy Resistance in Ewing Sarcoma
The University of North Carolina at Chapel Hill, Chapel Hill, NC
Investigating the role of PSAT1 in tumor-associated macrophages for sarcoma immunotherapy
Investigating the role of PSAT1 in tumor-associated macrophages for sarcoma immunotherapy
Case Western Reserve University - School of Medicine, Cleveland, OH
Epigenetic targeting of radiation resistant medulloblastoma
Epigenetic targeting of radiation resistant medulloblastoma
Johns Hopkins University, Baltimore, MD
Enhancement of Oncolytic Virotherapy with Directed Drug Delivery for Pediatric Brain Tumors
Enhancement of Oncolytic Virotherapy with Directed Drug Delivery for Pediatric Brain Tumors
MD Anderson Cancer Center, Houston, TX
Therapeutical reprogramming of DIPG cells
Therapeutical reprogramming of DIPG cells
Joan & Sanford I. Weill Medical College of Cornell University, New York, NY
PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy
PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy
University of Colorado Denver, AMC and DC, Aurora, CO